You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -9,470.8% | -600.3% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -16.7 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 1,501.2 | 75.8 |
| Price / Book value | 17.2 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | -69.3% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 32,110.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | n/a | -9.43 | -10.40p | -16.0 | 0.0 | n/a | n/a | 0.0% |
| 2016-12-31 | 0.77 | -10.36 | -12.10p | -8.3 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | 0.02 | -3.77 | -2.30p | -84.6 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | n/a | -20.53 | -26.20p | -2.0 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 0.24 | -22.87 | -26.10p | -13.4 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 4.75 | -28.54 | -29.14p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2021-12-31 | 10.85 | -28.49 | -26.05p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Mark Rothera joins Silence Therapeutics as new CEO Sharecast News | 14 Sep |
|---|---|
| Mallinckrodt exercises option for two licences from Silence Sharecast News | 16 Jul |
| Silence Therapeutics makes 'exceptional' year-to-date progress Sharecast News | 23 Jun |
| Holding(s) in Company | 23-Sep-20 09:01 |
|---|---|
| Second Price Monitoring Extn | 23-Sep-20 07:13 |
| Price Monitoring Extension | 23-Sep-20 07:12 |
| Second Price Monitoring Extn | 22-Sep-20 16:41 |
| Price Monitoring Extension | 22-Sep-20 16:37 |